ELIXIR for funders
Today, Europe’s life scientists face the following challenges:
- managing the data deluge
- integrating the data to reduce fragmentation of effort and research
- incorporating and exploiting new types of data
- maintainging open access to biological data in order to enhance competitiveness and innovation.
These challenges are too vast for any single institution or country, and must therefore be managed by joining forces at the European and global level.
The ESFRI Member States have realised this and included ELIXIR in the first European roadmap for research infrastructures in 2006.
The benefits of ELIXIR
Countries that become ELIXIR Member States will benefit from:
- enhanced exploitation of the data produced by their investments in biomedical research
- optimisation of the value of data by rapid and timely translation into other sectors such as clinical, agricultural and environment research
- enhanced competitiveness through European coordination
- enhanced bioinformatics capabilities and expertise within their funded communities
- facilitation of coherent strategic planning of their resource deployment.
The following fifteen countries have seen the benefits that ELIXIR will bring and have signed a Memorandum of Understanding (MoU) to participate.